Overview

A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833

Status:
Completed

Trial end date:
2024-02-19

Target enrollment:

Participant gender:

Summary

This is a study to evaluate the safety and efficacy of K-757 alone and in combination with K-833 versus placebo in participants who are obese.

Phase:

Phase 2

Details

Lead Sponsor:

Kallyope Inc.